BOLT BIOTHERAPEUTICS INC BOLT
COM NEW · Common Stock · CUSIP 097702203
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersRedwood City, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($336.7k this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $5.74.
Biggest buyers
| Vivo Capital, LLC | New | +176.1k |
| TANG CAPITAL MANAGEMENT LLC | New | +166.9k |
| Sofinnova Investments, Inc. | New | +137.7k |
| Pivotal bioVenture Partners Investment Advisor LLC | New | +94.6k |
| VANGUARD GROUP INC | New | +58.5k |
| Nan Fung Group Holdings Ltd | New | +58.3k |
| SAMSARA BIOCAPITAL, LLC | New | +52.5k |
| Board of Trustees of The Leland Stanford Junior University | New | +36.0k |
| Pfizer Inc | New | +31.3k |
| GEODE CAPITAL MANAGEMENT, LLC | New | +18.5k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| RENAISSANCE TECHNOLOGIES LLC 13G · institution new · filed 2026-08-13 | 5.1% |
Fell to 5% or below in the last year: Pivotal bioVenture Partners Fund I, L.P. (4.6%, 2026-02-26), Vivo Panda Fund, L.P. (3.8%, 2026-02-13)
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 4 | $9.1k | 1 | $176.8k | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 2 | $1.6k | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
| Q4 2024 | 2 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 2 | $686 | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-06-06 | Quinn William P. President, CEO and CFO, director | Bought | $686125 shares |
| 2025-06-06 | Nemec Sarah Senior VP, Finance and PAO | Bought | $686125 shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| Vivo Capital, LLC 0.10% of their portfolio | 176.1k $986.0k | New |
| TANG CAPITAL MANAGEMENT LLC 0.05% of their portfolio | 166.9k $962.9k | New |
| Sofinnova Investments, Inc. 0.05% of their portfolio | 137.7k $794.6k | New |
| Pivotal bioVenture Partners Investment Advisor LLC 0.34% of their portfolio | 94.6k $545.7k | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 58.5k $341.0k | New |
| Nan Fung Group Holdings Ltd 0.53% of their portfolio | 58.3k $336.7k | New |
| SAMSARA BIOCAPITAL, LLC 0.06% of their portfolio | 52.5k $302.7k | New |
| Board of Trustees of The Leland Stanford Junior University 0.02% of their portfolio | 36.0k $207.6k | New |
| Pfizer Inc 0.03% of their portfolio | 31.3k $180.6k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 18.5k $108.1k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 18.3k $105.7k | New |
| Squarepoint Ops LLC 0.00% of their portfolio | 12.4k $72.2k | New |
| ADAR1 Capital Management, LLC 0.01% of their portfolio | 10.8k $62.4k | New |
| BlackRock, Inc. 0.00% of their portfolio | 10.6k $60.9k | New |
| MORGAN STANLEY 0.00% of their portfolio | 3.6k $20.7k | New |
| NewEdge Advisors, LLC 0.00% of their portfolio | 483 $2.8k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 395 $2.3k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 282 $1.6k | New |
| UBS Group AG 0.00% of their portfolio | 183 $1.1k | New |
| FMR LLC 0.00% of their portfolio | 121 $705 | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 43 $251 | New |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 10 $58 | New |
| BARCLAYS PLC 0.00% of their portfolio | 6 $35 | New |
| SALEM INVESTMENT COUNSELORS INC 0.00% of their portfolio | 2 $12 | New |
| DANSKE BANK A/S 0.00% of their portfolio | 1 $6 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | New |